Develop tadekinig-alpha to treat inflammation
Member count: 11-50
Total raised: $20.886336M
Founded date: 2010

Investors 1

Funding Rounds 1

DateSeriesAmountInvestorsDeal News
14.01.2016Series B$20.886336...-startuptic...

Mentions in press and media 3

DateTitleDescriptionCategoryAuthorSource
03.03.2020AB2 Bio pr... Lausanne-based AB2 Bio Ltd i...Success-startuptic...
03.03.2020AB2 Bio pr...Lausanne-based AB2 Bio Ltd is ...Developmen...-startuptic...
14.01.2016AB2 Bio Lt... The successful financing of ...Financing-startuptic...